
BeLOVE: Berlin Longterm Observation of Vascular Events
The aim of BeLOVE is to improve prediction and mechanistic understanding of the course of cardiovascular diseases, both in the acute and chronic phase, in order to provide the basis for individualized disease management.
Read more3000 patients recruited into BeLOVE
In February 2022 the 3000th patient was successfully recruited into BeLOVE.
Learn more about numbers & facts of BeLOVEStart of the main phase of BeLOVE
After thorough piloting and establishment of infrastructures and investigation modules, the main phase of BeLOVE could be initiated as planned on January 1st, 2021.
Read moreComprehensive analyses of samples from the first 2000 patients started
After completion of enrollment of study participants for the establishment phase of BeLOVE on December 31st, 2020, initial analyses of the acute phase and 3-month follow-up of patients in this phase of the study were started in autumn at BIH's Core Facilities and other research groups.
Read moreStart of the Establishment Phase of BeLOVE
After thorough examination of the study feasiblity, the Establishment Phase of BeLOVE was started in March, 2018.
Read moreStart of the BeLOVE Pilot Phase
On July 17th, 2017 the Pilot Phase of BeLOVE was initiated.
Read more